Advertisement

Drugs in R & D

, Volume 3, Issue 6, pp 407–410 | Cite as

Ciclesonide

BY 9010, Ciclesonide-DPI, Ciclesonide-MDI, EL 876
Adis R&D Profile

Keywords

Asthma Allergic Rhinitis Fluticasone Propionate Beclomethasone Peak Expiratory Flow Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Richter K, Nielsen-Gode D, Biberger C, Nave R, Magnussen H. Oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in asthmatics. American Journal of Respiratory and Critical Care Medicine 165: 189, Part 2, Apr 2002Google Scholar
  2. 2.
    Timmer W, Weinbrenner A, Hüneke D, Zschiesche M, Engel G, et al. Repeated inhalation of the new topical steroid ciclesonide does not lead to adrenal suppression in healthy subjects. American Journal of Respiratory and Critical Care Medicine 161 (Suppl): 776 (plus poster), Part 2, Mar 2000Google Scholar
  3. 3.
    Postma DS, Sevette C, Martinat Y, Schlösser N, Aumann J, et al. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. European Respiratory Journal 17: 1083–1088, Jun 2001PubMedCrossRefGoogle Scholar
  4. 4.
    O′Connor B, Sips P, Engelstätter R, Steinijans VW, Wurst W. Management of moderate to severe bronchial asthma by ciclesonide: a 12-week trial. American Journal of Respiratory and Critical Care Medicine 165: 767, Part 2, Apr 2002Google Scholar
  5. 5.
    Jensen MW, Taylor DA, Englestatter R, et al. A novel inhaled steroid, ciclesonide, reduces airway responsiveness to AMP in a dose-related manner. American Journal of Respiratory and Critical Care Medicine 157 (Suppl): 406, Part 2, Mar 1998Google Scholar
  6. 6.
    Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, et al. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5′-monophosphate in asthmatic patients. American Journal of Respiratory and Critical Care Medicine 160: 237–243, Jul 1999PubMedGoogle Scholar
  7. 7.
    Engelstätter R, Langdon C, Bethke T, Rathgeb F, Steinijans VW, et al. Efficacy of ciclesonide after 12-week treatment of bronchial asthma. American Journal of Respiratory and Critical Care Medicine 165: 766, Part 2, Apr 2002Google Scholar
  8. 8.
    Chapman KR, D′Urzo AD, Oedekoven C, Steinijans VW, Wurst W. Effects of ciclesonide versus placebo on lung function after 12 weeks of treatment in patients with asthma. American Journal of Respiratory and Critical Care Medicine 165: 767, Part 2, Apr 2002Google Scholar
  9. 9.
    Timmer W, Schmidt BM, Georgens AC, Steinijans VW, Bethke T, et al. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. American Journal of Respiratory and Critical Care Medicine 161 (Suppl): 323 (plus poster), Part 2, Mar 2000Google Scholar

Copyright information

© Adis International Limited 2002

Personalised recommendations